CAMLX
Price
$48.96
Change
+$0.35 (+0.72%)
Updated
Jun 30 closing price
Net Assets
559.72M
GFACX
Price
$70.13
Change
+$0.36 (+0.52%)
Updated
Jun 30 closing price
Net Assets
320.84B
Interact to see
Advertisement

CAMLX vs GFACX

Header iconCAMLX vs GFACX Comparison
Open Charts CAMLX vs GFACXBanner chart's image
Congress Large Cap Growth Retail
Price$48.96
Change+$0.35 (+0.72%)
VolumeN/A
Net Assets559.72M
American Funds Growth Fund of Amer C
Price$70.13
Change+$0.36 (+0.52%)
VolumeN/A
Net Assets320.84B
CAMLX vs GFACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CAMLX vs. GFACX commentary
Jul 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAMLX is a StrongBuy and GFACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 321B vs. CAMLX (560M). CAMLX (0.00) and GFACX (0.00) have matching dividends . CAMLX was incepted earlier than GFACX: CAMLX (16 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than CAMLX (0.93). GFACX is a more actively managed with annual turnover of: 25.00 vs. CAMLX (19.00). GFACX has a lower initial minimum investment than CAMLX: GFACX (250) vs CAMLX (2000). GFACX annual gain was more profitable for investors over the last year : 9.02 vs. CAMLX (3.56). GFACX (38.43) and CAMLX (36.98) have equivalent 5 years return.
CAMLXGFACXCAMLX / GFACX
Total Expense Ratio0.931.3668%
Annual Report Gross Expense Ratio0.931.3668%
Fund Existence16 years24 years-
Gain YTD4.6739.42650%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets560M321B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year3.569.0239%
Returns for 3 years48.6450.8996%
Returns for 5 years36.9838.4396%
Returns for 10 years119.2864.67184%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LSTA2.900.10
+3.54%
Lisata Therapeutics
HUBS556.636.00
+1.09%
HUBSPOT
CDTX48.71-0.74
-1.50%
Cidara Therapeutics
RUSHB52.48-1.18
-2.20%
Rush Enterprises
FSP1.64-0.06
-3.53%
Franklin Street Properties Corp